BioSpace News Archive

Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced that it has signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universitat Dresden (TU Dresden).

RPM International Inc. announced that its board of directors has declared a regular quarterly cash dividend of $0.32 per share, payable on July 31, 2018 to stockholders of record as of July 17, 2018.

The UK based developer of next generation proton therapy technology, Advanced Oncotherapy plc (AVO), has selected RayStation as its treatment planning system for the first LIGHT (Linac Image Guided Hadron Technology) system at the proton therapy facility under construction at Harley Street in central London.

World’s largest tissue bank to unveil new cartilage allograft and showcase portfolio of innovations for sports medicine

Fibrocell Science, Inc. announced the closing of its previously announced registered direct offering of 1,474,080 shares of its common stock which was priced at-the-market at a purchase price of $2.69 per share

HCP is scheduled to report its second quarter 2018 financial results on Thursday, August 2, 2018

AmerisourceBergen Corporation announced that it plans to release its results for the Third Quarter Fiscal 2018 on Thursday, August 2, 2018

McKesson Corporation will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018

Acceleron Pharma Inc. announced the appointment of Robert K. Zeldin, M.D., as Chief Medical Officer (CMO). Dr. Zeldin brings to Acceleron more than two decades of clinical, regulatory

Efforts Aimed at Extending Cash Runway to mid-2019